Dr. Mark Russo, MD

Internal Medicine Greensboro, NC Male
NPI: 1588745392
Total Payments
$318,372
2024 Payments
$780.90
Companies
21
Transactions
320
Medicare Patients
967
Medicare Billing
$73,063

Payment Breakdown by Category

Other$251,900 (79.1%)
Consulting$33,625 (10.6%)
Travel$19,688 (6.2%)
Food & Beverage$10,859 (3.4%)
Research$2,300 (0.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $144,100 54 45.3%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $100,800 27 31.7%
Consulting Fee $33,625 22 10.6%
Travel and Lodging $19,688 66 6.2%
Food and Beverage $10,859 139 3.4%
Honoraria $7,000 7 2.2%
Unspecified $2,300 5 0.7%

Payments by Type

General
$316,072
315 transactions
Research
$2,300
5 transactions

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $119,252 131 $0 (2022)
Intercept Pharmaceuticals, Inc. $63,862 49 $0 (2019)
Valeant Pharmaceuticals North America LLC $42,356 28 $0 (2017)
Merck Sharp & Dohme Corporation $24,662 27 $0 (2020)
Dova Pharmaceuticals $21,150 12 $0 (2019)
Bayer HealthCare Pharmaceuticals Inc. $15,512 23 $0 (2017)
ABBVIE INC. $11,491 19 $0 (2022)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $8,867 8 $0 (2021)
SANOFI US SERVICES INC. $3,875 1 $0 (2017)
Eli Lilly and Company $3,800 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $780.90 3 Eli Lilly and Company ($600.00)
2023 $3,522 4 Eli Lilly and Company ($3,200)
2022 $1,366 11 ModernaTX, Inc. ($700.00)
2021 $1,698 2 Moderna TX, Inc. ($1,600)
2020 $2,260 7 Merck Sharp & Dohme Corporation ($2,000)
2019 $99,432 80 Gilead Sciences, Inc. ($39,392)
2018 $72,019 80 Gilead Sciences, Inc. ($39,991)
2017 $137,295 133 Valeant Pharmaceuticals North America LLC ($42,356)

All Payment Transactions

320 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
12/07/2024 Edwards Lifesciences Corporation — Food and Beverage In-kind items and services $138.55 General
07/16/2024 ABIOMED Impella (Device) Food and Beverage Cash or cash equivalent $42.35 General
Category: Cardiology/Vascular Diseases
06/05/2024 Eli Lilly and Company — Consulting Fee Cash or cash equivalent $600.00 General
10/16/2023 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $121.53 General
Category: CRITICAL CARE
09/09/2023 DePuy Synthes Sales Inc. MATRIXMANDIBLE (Device) Food and Beverage In-kind items and services $39.60 General
Category: CMF-Trauma
06/23/2023 Boston Scientific Corporation — Food and Beverage In-kind items and services $161.02 General
Category: General - Therapies_PI
06/16/2023 Eli Lilly and Company — Consulting Fee Cash or cash equivalent $3,200.00 General
12/06/2022 Gilead Sciences, Inc. Epclusa (Drug) Food and Beverage In-kind items and services $123.38 General
Category: HCV
10/24/2022 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $101.14 General
10/14/2022 DePuy Synthes Sales Inc. MATRIXMIDFACE (Device) Food and Beverage In-kind items and services $32.90 General
Category: CMF-Trauma
09/06/2022 ModernaTX, Inc. Moderna Covid-19 Vaccine (Biological) — Cash or cash equivalent $100.00 Research
Study: A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls • Category: Infections and Infectious Diseases
08/18/2022 ModernaTX, Inc. Moderna Covid-19 Vaccine (Biological) — Cash or cash equivalent $100.00 Research
Study: A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls • Category: Infections and Infectious Diseases
08/02/2022 Vifor Pharma, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $24.47 General
Category: Hyperkalemia
07/21/2022 Abbott Laboratories MITRACLIP (Device) Food and Beverage In-kind items and services $137.92 General
Category: Structural Heart
07/07/2022 ModernaTX, Inc. Moderna Covid-19 Vaccine (Biological) — Cash or cash equivalent $300.00 Research
Study: A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls • Category: Infections and Infectious Diseases
06/02/2022 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $121.99 General
03/11/2022 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $124.21 General
Category: VIROLOGY
02/02/2022 ModernaTX, Inc. Moderna Covid-19 Vaccine (Biological) — Cash or cash equivalent $200.00 Research
Study: A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls • Category: Infections and Infectious Diseases
10/07/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $97.51 General
Category: Gastroenterology
09/09/2021 Moderna TX, Inc. Moderna Covid-19 Vaccine (Biological) — Cash or cash equivalent $1,600.00 Research
Study: A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls • Category: Infections and Infectious Diseases
11/20/2020 ABIOMED Impella (Device) Food and Beverage In-kind items and services $18.17 General
Category: Cardiology/Vascular Diseases
11/18/2020 ABIOMED Impella (Device) Food and Beverage In-kind items and services $36.64 General
Category: Cardiology/Vascular Diseases
09/04/2020 ABIOMED Impella (Device) Food and Beverage In-kind items and services $29.25 General
Category: Cardiology/Vascular Diseases
03/27/2020 Abbott Laboratories Mitra Clip system (Device) Food and Beverage In-kind items and services $162.14 General
Category: Vascular
02/21/2020 Merck Sharp & Dohme Corporation STEGLATRO (Drug) Consulting Fee Cash or cash equivalent $1,000.00 General
Category: ENDOCRINOLOGY
123…13»

Research Studies & Clinical Trials

Study Name Company Amount Records
A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls Moderna TX, Inc. $1,600 1
A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls ModernaTX, Inc. $700.00 4

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 223 293 $80,980 $17,341
2022 6 209 268 $60,927 $15,222
2021 9 277 378 $51,970 $24,177
2020 8 258 326 $42,912 $16,322
Total Patients
967
Total Services
1,265
Medicare Billing
$73,063
Procedure Codes
28

All Medicare Procedures & Services

28 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 110 155 $47,860 $9,820 20.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 65 74 $16,280 $3,261 20.0%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 18 18 $9,630 $2,501 26.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 11 27 $6,507 $1,623 24.9%
91200 Measurement of liver stiffness Facility 2023 19 19 $703.00 $135.83 19.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 88 123 $31,716 $7,832 24.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 64 69 $12,881 $3,084 23.9%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 18 18 $7,552 $2,390 31.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 14 20 $4,720 $1,076 22.8%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 12 25 $3,200 $749.00 23.4%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Facility 2022 13 13 $858.00 $90.92 10.6%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 101 146 $15,753 $10,617 67.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 24 62 $10,292 $3,491 33.9%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 26 26 $5,911 $3,430 58.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 12 13 $7,403 $2,023 27.3%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 33 33 $2,366 $1,417 59.9%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 12 12 $5,064 $1,294 25.6%
99212 Established patient outpatient visit, total time 10-19 minutes Facility 2021 36 38 $1,513 $912.59 60.3%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 14 28 $2,828 $836.36 29.6%
91200 Measuring the stiffness in the liver via elastography Facility 2021 19 20 $840.00 $156.24 18.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 81 113 $10,063 $5,484 54.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 28 55 $8,910 $3,008 33.8%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 23 23 $5,049 $3,004 59.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 14 16 $9,056 $2,493 27.5%
99212 Established patient office or other outpatient visit, typically 10 minutes Facility 2020 43 48 $4,164 $958.57 23.0%
12»

About Dr. Mark Russo, MD

Dr. Mark Russo, MD is a Internal Medicine healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588745392.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Russo, MD has received a total of $318,372 in payments from pharmaceutical and medical device companies, with $780.90 received in 2024. These payments were reported across 320 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($144,100).

As a Medicare-enrolled provider, Russo has provided services to 967 Medicare beneficiaries, totaling 1,265 services with total Medicare billing of $73,063. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Gastroenterology, Transplant Hepatology
  • Location Greensboro, NC
  • Active Since 10/18/2006
  • Last Updated 07/15/2024
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1588745392

Products in Payments

  • Epclusa (Drug) $64,130
  • OCALIVA (Drug) $55,745
  • XIFAXAN (Drug) $51,222
  • Vemlidy (Drug) $29,395
  • Doptelet (Drug) $21,150
  • Stivarga (Drug) $15,512
  • STEGLATRO (Drug) $10,800
  • OCA (Drug) $8,117
  • ZEPATIER (Drug) $7,379
  • Mavyret (Drug) $7,263
  • Viekira (Drug) $4,104
  • MULTAQ (Drug) $3,875
  • Moderna Covid-19 Vaccine (Biological) $2,300
  • Vosevi (Drug) $350.00
  • SIR-Spheres Microspheres (Device) $162.85
  • Mitra Clip system (Device) $162.14
  • Impella (Device) $140.02
  • MITRACLIP (Device) $137.92
  • Lenvima (Drug) $125.00
  • MAVYRET (Drug) $124.21

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Greensboro

Dr. Daniel Bensimhon, Md, MD

Internal Medicine — Payments: $2.3M

Internal Medicine $2.3M

Dr. Michael Wert, M.d, M.D

Internal Medicine — Payments: $439,242

Internal Medicine $439,242

Julian Hutchins, Md, MD

Internal Medicine — Payments: $222,266

Internal Medicine $222,266

Dr. James Beekman, Md, MD

Internal Medicine — Payments: $116,445

Internal Medicine $116,445

Walter Pharr, M.d, M.D

Internal Medicine — Payments: $53,823

Internal Medicine $53,823

Murali Ramaswamy, Md Faafp, MD FAAFP

Internal Medicine — Payments: $45,364

Internal Medicine $45,364